South Korea vs Saudi Arabia: Share of newborns vaccinated against tuberculosis
South Korea
97.0%
in 2024
Saudi Arabia
97.0%
in 2024
South Korea rank
53rd
Saudi Arabia rank
53rd
Share of newborns vaccinated against tuberculosis over time
- South Korea
- Saudi Arabia
How they compare
South Korea currently reports 97.0% against 97.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 12 times across 44 shared years of data; in 1981 it was Saudi Arabia ahead.
South Korea ranks 53rd and Saudi Arabia ranks 53rd of 166 countries.
Across the 5 decades both report, South Korea averaged higher in 2 and Saudi Arabia in 3.
Head to head by decade
| Decade | South Korea | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 50.3% | 80.4% | 30.1% | Saudi Arabia |
| 1990s | 83.8% | 91.3% | 7.5% | Saudi Arabia |
| 2000s | 90.6% | 95.8% | 5.2% | Saudi Arabia |
| 2010s | 98.1% | 93.6% | 4.5% | South Korea |
| 2020s | 97.8% | 96.0% | 1.8% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of newborns vaccinated against tuberculosis, South Korea or Saudi Arabia?
- South Korea, at 97.0% against 97.0% in Saudi Arabia as of 2024.
- What is the difference in share of newborns vaccinated against tuberculosis between South Korea and Saudi Arabia?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Saudi Arabia?
- 44 years are reported by both, from 1981 to 2024.
- How do South Korea and Saudi Arabia rank globally for share of newborns vaccinated against tuberculosis?
- South Korea ranks 53rd and Saudi Arabia ranks 53rd of 166 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of newborns vaccinated against tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of newborns who have had one dose of the tuberculosis (BCG) vaccine in a given year.